{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T02:56:47Z","timestamp":1770087407421,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-NHRI10405"],"award-info":[{"award-number":["TCVGH-NHRI10405"]}]},{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-1047324D"],"award-info":[{"award-number":["TCVGH-1047324D"]}]},{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-1047312C"],"award-info":[{"award-number":["TCVGH-1047312C"]}]},{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-104G211"],"award-info":[{"award-number":["TCVGH-104G211"]}]},{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-VHCY1058603"],"award-info":[{"award-number":["TCVGH-VHCY1058603"]}]},{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-1054002B"],"award-info":[{"award-number":["TCVGH-1054002B"]}]},{"DOI":"10.13039\/501100001868","name":"National Science Council, Taiwan","doi-asserted-by":"crossref","award":["MOST 103-2314-B-075A-006"],"award-info":[{"award-number":["MOST 103-2314-B-075A-006"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.schres.2016.03.027","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T06:34:09Z","timestamp":1460183649000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study"],"prefix":"10.1016","volume":"174","author":[{"given":"Po-Han","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6911-1839","authenticated-orcid":false,"given":"Che-Sheng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Huey","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuo-Hung","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.schres.2016.03.027_bb0005","first-page":"141","article-title":"Serotonin (5-HT) and the rat's eye. Some pilot studies. Documenta ophthalmologica","volume":"82","author":"Boerrigter","year":"1992","journal-title":"Adv. Ophthalmol."},{"issue":"5","key":"10.1016\/j.schres.2016.03.027_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"5","key":"10.1016\/j.schres.2016.03.027_bb0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","article-title":"Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study","volume":"200","author":"Chen","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2016.03.027_bb0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ps.2007.58.4.554","article-title":"Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997\u20132004","volume":"58","author":"Chien","year":"2007","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/schbul\/sbu086","article-title":"Similar age-related decline in cortical activity over frontotemporal regions in schizophrenia: a multichannel near-infrared spectroscopy study","volume":"41","author":"Chou","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2016.03.027_bb0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpsychires.2015.06.017","article-title":"Risk of depressive disorders in women undergoing hysterectomy: a population-based follow-up study","volume":"68","author":"Chou","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2016.03.027_bb0035","doi-asserted-by":"crossref","first-page":"18069","DOI":"10.1038\/srep18069","article-title":"Duration of untreated psychosis and brain function during verbal fluency testing in first-episode schizophrenia: a near-infrared spectroscopy study","volume":"5","author":"Chou","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2016.03.027_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pnpbp.2013.11.009","article-title":"Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study","volume":"49","author":"Chou","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.03.027_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00787-012-0369-3","article-title":"Prevalence of allergic rhinitis in patients with attention-deficit\/hyperactivity disorder: a population-based study","volume":"22","author":"Chou","year":"2013","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.03.027_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.psym.2013.06.003","article-title":"Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study","volume":"55","author":"Chou","year":"2014","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.schres.2016.03.027_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.psym.2012.03.007","article-title":"Panic disorder and risk of stroke: a population-based study","volume":"53","author":"Chou","year":"2012","journal-title":"Psychosomatics"},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.03.027_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2011.02.018","article-title":"The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study","volume":"129","author":"Chou","year":"2011","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2016.03.027_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00023210-200418080-00001","article-title":"SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms","volume":"18","author":"Costagliola","year":"2004","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.schres.2016.03.027_bb0070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archopht.1997.01100160466015","article-title":"Alcohol, smoking, and cataracts: the Blue Mountains eye study","volume":"115","author":"Cumming","year":"1997","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.schres.2016.03.027_bb0075","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.schres.2016.03.027_bb0080","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ajo.2013.12.008","article-title":"The association between cataract surgery and atypical antipsychotic use: a nested case-control study","volume":"157","author":"El Sanharawi","year":"2014","journal-title":"Am J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2014.03.006","article-title":"Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study","volume":"158","author":"Erie","year":"2014","journal-title":"Am J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.schres.2016.03.027_bb0090","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1183\/09031936.06.00043005","article-title":"Low-dose inhaled and nasal corticosteroid use and the risk of cataracts","volume":"27","author":"Ernst","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.schres.2016.03.027_bb0095","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ophtha.2009.11.042","article-title":"Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study","volume":"117","author":"Etminan","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.schres.2016.03.027_bb0100","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajo.2004.05.038","article-title":"Twice-yearly exams unnecessary for patients taking quetiapine","volume":"138","author":"Fraunfelder","year":"2004","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.schres.2016.03.027_bb0105","first-page":"663","article-title":"Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy","volume":"90","author":"Greiner","year":"1964","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bjo.77.1.2","article-title":"Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies","volume":"77","author":"Harding","year":"1993","journal-title":"Br. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.schres.2016.03.027_bb0115","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/pon.3277","article-title":"Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population-based study","volume":"22","author":"Hung","year":"2013","journal-title":"Psycho-Oncology"},{"issue":"9","key":"10.1016\/j.schres.2016.03.027_bb0120","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0161-6420(01)00656-X","article-title":"Drug use and five-year incidence of age-related cataracts: the Beaver Dam eye study","volume":"108","author":"Klein","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.schres.2016.03.027_bb0125","series-title":"Abstracts of the 39th Annual Meeting of the American College of Neuropsychopharmacology","article-title":"Safety update on lenticular opacities: benign experience with 620,000 US patient exposures to quetiapine","author":"Laties","year":"2000"},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0269881114553253","article-title":"Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial","volume":"29","author":"Laties","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.schres.2016.03.027_bb0135","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.schres.2016.03.027_bb0140","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.schres.2016.03.027_bb0145","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.161.8.1334","article-title":"Physical health monitoring of patients with schizophrenia","volume":"161","author":"Marder","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2016.03.027_bb0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0161-6420(99)90151-3","article-title":"Schizophrenia, psychotropic medication, and cataract","volume":"106","author":"McCarty","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.schres.2016.03.027_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"issue":"4","key":"10.1016\/j.schres.2016.03.027_bb0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0161-6420(97)30266-8","article-title":"Prevalence of cataract in Australia: the Blue Mountains eye study","volume":"104","author":"Mitchell","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.schres.2016.03.027_bb0165","series-title":"Abstracts of the 38th Annual Meeting of the American College of Neuropsychopharmacology","article-title":"Safety update with quetiapine and lenticular examinations: experience with 300,000 patients","author":"Nasrallah","year":"1999"},{"issue":"6","key":"10.1016\/j.schres.2016.03.027_bb0170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ajo.2013.07.012","article-title":"The association between cataract surgery and atypical antipsychotic use: a nested case-control study","volume":"156","author":"Pakzad-Vaezi","year":"2013","journal-title":"Am J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.schres.2016.03.027_bb0175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","article-title":"Ocular adverse effects of common psychotropic agents: a review","volume":"24","author":"Richa","year":"2010","journal-title":"CNS Drugs"},{"issue":"Suppl. 10","key":"10.1016\/j.schres.2016.03.027_bb0180","first-page":"5","article-title":"Receptor pharmacology of neuroleptics: relation to clinical effects","volume":"60","author":"Richelson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.03.027_bb0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ophtha.2011.09.005","article-title":"Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino Eye Study","volume":"119","author":"Richter","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.schres.2016.03.027_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1076\/0928-6586(200006)721-ZFT103","article-title":"Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains eye study","volume":"7","author":"Rowe","year":"2000","journal-title":"Ophthalmic Epidemiol."},{"issue":"6","key":"10.1016\/j.schres.2016.03.027_bb0195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00001648-200011000-00002","article-title":"Are schizophrenia or antipsychotic drugs a risk factor for cataracts?","volume":"11","author":"Ruigomez","year":"2000","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.schres.2016.03.027_bb0200","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/appi.psy.43.5.354","article-title":"Cataract occurrence with antipsychotic drugs","volume":"43","author":"Shahzad","year":"2002","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.schres.2016.03.027_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1590\/S1516-44462008000300008","article-title":"Cataract occurrence in patients treated with antipsychotic drugs","volume":"30","author":"Souza","year":"2008","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(14)73812-7","article-title":"Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes","volume":"119","author":"Thompson","year":"1995","journal-title":"Am J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.2051-5545.2008.tb00154.x","article-title":"Side effects of atypical antipsychotics: a brief overview","volume":"7","author":"Ucok","year":"2008","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.03.027_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/02713688909013899","article-title":"Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens","volume":"8","author":"Vivekanandan","year":"1989","journal-title":"Curr. Eye Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.03.027_bb0225","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.schres.2004.02.010","article-title":"Quetiapine treatment in early psychosis: no evidence of cataracts","volume":"71","author":"Whitehorn","year":"2004","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2016.03.027_bb0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/bjo.2005.083733","article-title":"The epidemiology of age related eye diseases in Asia","volume":"90","author":"Wong","year":"2006","journal-title":"Br. J. Ophthalmol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416301207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416301207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T10:29:58Z","timestamp":1600424998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416301207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":46,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0920996416301207"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.03.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}